Febvret A, Berger B, Gaspar P, Verney C. 1991. Further indication that
distinct dopaminergic subsets project to the rat cerebral cortex: lack of
colocalization with neurotensin in the superficial dopaminergic fields of
the anterior cingulate, motor, retrosplenial and visual cortices. Brain
Res 547:37–52.
Feng N, Mo B, Johnson PL, Orchinik M, Lowry CA, Renner KJ. 2005. Local
inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus. Brain Res 1063:69 –76.
Fuxe K, Jacobsen KX, Hoistad M, Tinner B, Jansson A, Staines WA, Agnati
LF. 2003. The dopamine D1 receptor-rich main and paracapsular
intercalated nerve cell groups of the rat amygdala: relationship to the
dopamine innervation. Neuroscience 119:733–746.
Gasser PJ, Lowry CA, Orchinik M. 2006. Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for
organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 26:8758 – 8766.
Grundemann D, Schomig E. 2000. Gene structures of the human nonneuronal monoamine transporters EMT and OCT2. Hum Genet 106:627–
635.
Grundemann D, Schechinger B, Rappold GA, Schomig E. 1998. Molecular
identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1:349 –351.
Grundemann D, Liebich G, Kiefer N, Koster S, Schomig E. 1999. Selective
substrates for non-neuronal monoamine transporters. Mol Pharmacol
56:1–10.
Haag C, Berkels R, Grundemann D, Lazar A, Taubert D, Schomig E. 2004.
The localisation of the extraneuronal monoamine transporter (EMT) in
rat brain. J Neurochem 88:291–297.
Hamlet MA, Rorie DK, Tyce GM. 1980. Effects of estradiol on release and
disposition of norepinephrine from nerve endings. Am J Physiol 239:
H450 –H456.
Horvath G, Lieb T, Conner GE, Salathe M, Wanner A. 2001. Steroid
sensitivity of norepinephrine uptake by human bronchial arterial and
rabbit aortic smooth muscle cells. Am J Respir Cell Mol Biol 25:500 –
506.
Horvath G, Sutto Z, Torbati A, Conner GE, Salathe M, Wanner A. 2003.
Norepinephrine transport by the extraneuronal monoamine transporter
in human bronchial arterial smooth muscle cells. Am J Physiol Lung
Cell Mol Physiol 285:829 – 837.
Inazu M, Takeda H, Matsumiya T. 2003. Expression and functional characterization of the extraneuronal monoamine transporter in normal
human astrocytes. J Neurochem 84:43–52.
Iversen LL. 1965. The uptake of catecholamines at high perfusion concentrations in the rat isolated heart. A novel catecholamine uptake process. Br J Pharmacol Chemother 25:18 –33.
Iversen LL. 1971. Role of transmitter uptake mechanisms in synaptic
neurotransmission. Br J Pharmacol 41:571–591.
Iversen LL, Salt PJ. 1970. Inhibition of catecholamine uptake-2 by steroids
in the isolated rat heart. Br J Pharmacol 40:528 –530.
Iversen LL, Jarrott B, Simmonds MA. 1971. Differences in the uptake,
storage and metabolism of ( )- and (–)-noradrenaline. Br J Pharmacol
43:845– 855.
Jacobs BL, Azmitia EC. 1992. Structure and function of the brain serotonin
system. Physiol Rev 72:165–229.
Jayanthi LD, Ramamoorthy S. 2005. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.
AAPS J 7:E728 –E738.
Johnson SM, de la Lande I. 1978. Action of deoxycorticosterone acetate
on the central artery of the rabbit ear. Blood Vessels 15:231–246.
Kalivas PW, Duffy P. 1995. Selective activation of dopamine transmission
in the shell of the nucleus accumbens by stress. Brain Res 675:325–
328.
Karschin A, Wischmeyer E, Davidson N, Lester HA. 1994. Fast inhibition of
inwardly rectifying K channels by multiple neurotransmitter receptors
in oligodendroglia. Eur J Neurosci 6:1756 –1764.
Kitaichi K, Morishita Y, Doi Y, Ueyama J, Matsushima M, Zhao YL, Takagi
K, Hasegawa T. 2003. Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats. Eur
J Pharmacol 464:39 – 48.
Kitaichi K, Fukuda M, Nakayama H, Aoyama N, Ito Y, Fujimoto Y, Takagi
K, Takagi K, Hasegawa T. 2005. Behavioral changes following antisense oligonucleotide-induced reduction of organic cation
transporter-3 in mice. Neurosci Lett 382:195–200.
Kristufek D, Rudorfer W, Pifl C, Huck S. 2002. Organic cation transporter
